Area 23 netted three gold awards, and 2e Creative won Small Agency of the Year for the third year in a row.
Two point-of-care companies have received hundreds of millions of dollars in funding. One of them, Outcome Health, is facing allegations about padding data.
Linda Ruschau, chief client officer of PatientPoint, talks with Larry Dobrow, senior editor at MM&M, about how to better engage with HCPs. The questions and topic were created and selected by the MM&M editorial staff. The video is sponsored by PatientPoint.
From IKEA to eye-opening health campaigns, S&S Wellness' CCO helps turn emotion into action.
The organization rolled out a video this week as part of its Live Unaddicted campaign to change the perception of addiction treatment.
Merck lays off 1,800 employees, launches new sales force; Celgene ends development of Crohn's disease drug; PBMs come under increased scrutiny
The FDA approves Kite's CAR-T therapy; Omnicom reports strong Q3 performance for healthcare agencies; Hearst to acquire Rodale, up health presence
More than half of doctors say patients make critical, racist, or sexist comments; Anthem to launch its own PBM; drugmakers face criticism for waste
An FDA advisory committee is scheduled to vote Wednesday on whether to approve Novo's semaglutide, which, if approved, could steal market share from Eli Lilly's Trulicity.
The health startup's system has a foot scanner that can take photos of a patient's feet and can look for potential foot ulcers using a machine learning image classifier.
J&J reports 15% lift in pharma sales in Q3; Apple reportedly considers buying medical clinics; survey finds need for digital investment in payer marketing
Like its consumer-products cousins, pharma marketers are exercising more discipline over online media. Will it yield similar results?
FDA briefing document affirms diabetes drug's efficacy; J&J debuts new tools to improve adherence; AZ says cancer drug data was falsified
Two key creators from Ready Set Rocket share how a thoughtful execution can destigmatize mental illness.
Outcome Health reportedly misled advertisers; FDA committee recommends gene therapy; Avanir drug is highly prescribed by docs paid by company
The association said it is preparing for new FDA approvals for therapies that treat central nervous system and muscular system diseases.
Merck scraps plans for cholesterol drug; oncologist describes how he tells people about his work; researchers question list of side effects in DTC ads
Susan G. Komen and the Breast Cancer Research Foundation are focusing on raising awareness and research money for the deadliest forms of the disease.